Literature DB >> 12738336

Analysis of interaction between number of implant catheters and dose-volume histograms in prostate high- dose-rate brachytherapy using a computer model.

Claire Charra-Brunaud1, I-Chow J Hsu, Vivian Weinberg, Jean Pouliot.   

Abstract

PURPOSE: In prostate high-dose-rate brachytherapy, to determine before implant, using the standard geometric optimization algorithm, whether there is an optimal number of catheters.
MATERIALS AND METHODS: Transrectal ultrasound images of the prostate from 24 patients were transferred into the brachytherapy planning system. Urethra and prostate contours were digitized onto each axial slice of a CT scan, as well as hypothetical locations of the catheters (2/3 of the catheters along the prostate contour, 1/3 around the urethra). Each prostate was implanted with 9, 12, 15, 18, and 21 catheters. Dosimetry was optimized using a geometric optimization algorithm; prescription isodose was chosen so that 95% of planning target volume was covered by the 100% isodose.
RESULTS: A significant increase in mean volume of prostate receiving 150% of the dose (V150) when the number of catheters decreased (p < 0.0001). The 9-catheter group significantly differed from each of the other groups; no difference was seen in V150 among the 21-, 18-, and 15-catheter groups. Parallel results were observed for urethra V150 and homogeneity index; there was no difference in conformity index by catheter group.
CONCLUSION: V150 increased when fewer catheters were used. There was no significant difference among the 21-, 18-, and 15-catheter groups: the geometric optimization routine probably compensated for the larger distance between dwell positions. Based on the technique described in our study, we conclude that 15 to 21 catheters seem to cover the prostate adequately without creating excess hot spots.

Entities:  

Mesh:

Year:  2003        PMID: 12738336     DOI: 10.1016/s0360-3016(03)00131-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  The effect of needle number on the quality of high-dose-rate prostate brachytherapy implants.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; Csaba Polgár; Tibor Major
Journal:  Pathol Oncol Res       Date:  2010-03-25       Impact factor: 3.201

2.  Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.

Authors:  Georgina Fröhlich; Péter Agoston; József Lövey; András Somogyi; János Fodor; Csaba Polgár; Tibor Major
Journal:  Strahlenther Onkol       Date:  2010-06-24       Impact factor: 3.621

3.  The impact of prostate volume changes during external-beam irradiation in consequence of HDR brachytherapy in prostate cancer treatment.

Authors:  Markus Karl Alfred Herrmann; Tammo Gsänger; Arne Strauss; Tereza Kertesz; Hendrik A Wolff; Hans Christiansen; Hilke Vorwerk; Clemens Friedrich Hess; Andrea Hille
Journal:  Strahlenther Onkol       Date:  2009-06-09       Impact factor: 3.621

4.  Dosimetric analysis of radiation therapy oncology group 0321: the importance of urethral dose.

Authors:  I-Chow Hsu; Daniel Hunt; William Straube; Jean Pouliot; Adam Cunha; Devan Krishnamurthy; Howard Sandler
Journal:  Pract Radiat Oncol       Date:  2013-03-29

5.  An audit of high dose-rate prostate brachytherapy treatment planning at six Swedish clinics.

Authors:  Frida Dohlmar; Sakarias Johansson; Torbjörn Larsson; Michael Sandborg; Åsa Carlsson Tedgren
Journal:  J Contemp Brachytherapy       Date:  2021-02-18

6.  Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer.

Authors:  Adam Chicheł; Marek Kanikowski; Janusz Skowronek
Journal:  J Contemp Brachytherapy       Date:  2009-10-08

7.  Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high-dose-rate brachytherapy (HDR-BT) as a boost.

Authors:  Adam Chicheł; Marek Kanikowski; Janusz Skowronek; Magdalena Dymnicka; Tomasz Piotrowski
Journal:  J Contemp Brachytherapy       Date:  2009-03-23

8.  Phase I study of dose escalation to dominant intraprostatic lesions using high-dose-rate brachytherapy.

Authors:  Christopher H Chapman; Steve E Braunstein; Jean Pouliot; Susan M Noworolski; Vivian Weinberg; Adam Cunha; John Kurhanewicz; Alexander R Gottschalk; Mack Iii Roach; I-Chow Hsu
Journal:  J Contemp Brachytherapy       Date:  2018-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.